PROM1 and glioma: Some studies have shown that not all high grade gliomas express CD13311 and also, that CD133 negative cell populations from GBM may have tumour initiating potential12, giving rise to CD133+ tumours.13–15 The role of this marker in further steps of tumour progression is not known.